Myeloproliferative Neoplasms News

More than two-thirds of patients with myeloproliferative neoplasms reported experiencing some degree of sexual dysfunction, according to prospective study results from the Myeloproliferative Neoplasms Quality of Life International Study Group.

More than two-thirds of patients with myeloproliferative neoplasms reported experiencing some degree of sexual dysfunction, according to prospective study results from the Myeloproliferative Neoplasms Quality of Life International Study Group.

Patients treated in phase 1 trials designed with a biomarker-based approach for treatment selection demonstrated higher response rates and longer PFS, according to results of a meta-analysis scheduled for presentation at the ASCO Annual Meeting.

The U.S. House Energy Subcommittee on Health today held a hearing to offer doctor and patient perspectives on planned changes to the Medicare Part B drug reimbursement model.

Preliminary data from a small randomized study showed light therapy decreased depressive symptoms and normalized circadian rhythms among cancer survivors.

Heather S.L. Jim, PhD, of the health outcomes and behavior program at Moffitt Cancer Center, and colleagues analyzed data from previously published studies that examined spirituality and its association with outcomes among more than 32,000 patients with cancer. They found that patients with higher levels of spiritual well-being reported better emotional, physical and social health.

The administration of cyclophosphamide following a mobilized blood cell transplant appeared associated with a lower incidence of chronic graft-versus-host disease, according to findings from a study conducted at Fred Hutchinson Cancer Research Center.

In team sports, home-field advantage appears to be a real phenomenon. Although the exact causes are not clear — despite having been extensively investigated — there seem to be intangible, difficult-to-define reasons why teams do better in familiar surroundings with a strong support system.

Nausea and vomiting are two of the most distressing and potentially debilitating effects of cancer treatment.

Environmental exposure to residential radon may increase the risk for hematologic malignancies in women, according to the results of a population study.